AtriCure Current Ratio 2011-2025 | ATRC
AtriCure current ratio from 2011 to 2025. Current ratio can be defined as a liquidity ratio that measures a company's ability to pay short-term obligations.
| AtriCure Current Ratio Historical Data | |||
|---|---|---|---|
| Date | Current Assets | Current Liabilities | Current Ratio |
| 2025-09-30 | $0.30B | $0.08B | 3.87 |
| 2025-06-30 | $0.27B | $0.07B | 3.94 |
| 2025-03-31 | $0.25B | $0.06B | 4.11 |
| 2024-12-31 | $0.27B | $0.07B | 3.65 |
| 2024-09-30 | $0.27B | $0.07B | 3.62 |
| 2024-06-30 | $0.25B | $0.06B | 4.13 |
| 2024-03-31 | $0.25B | $0.06B | 4.00 |
| 2023-12-31 | $0.27B | $0.08B | 3.57 |
| 2023-09-30 | $0.25B | $0.08B | 3.06 |
| 2023-06-30 | $0.24B | $0.07B | 3.33 |
| 2023-03-31 | $0.24B | $0.06B | 3.82 |
| 2022-12-31 | $0.22B | $0.06B | 3.69 |
| 2022-09-30 | $0.21B | $0.06B | 3.69 |
| 2022-06-30 | $0.21B | $0.06B | 3.66 |
| 2022-03-31 | $0.20B | $0.05B | 4.21 |
| 2021-12-31 | $0.20B | $0.06B | 3.47 |
| 2021-09-30 | $0.20B | $0.05B | 3.63 |
| 2021-06-30 | $0.24B | $0.07B | 3.50 |
| 2021-03-31 | $0.30B | $0.06B | 5.10 |
| 2020-12-31 | $0.31B | $0.05B | 6.24 |
| 2020-09-30 | $0.30B | $0.05B | 6.62 |
| 2020-06-30 | $0.29B | $0.04B | 7.68 |
| 2020-03-31 | $0.13B | $0.04B | 3.25 |
| 2019-12-31 | $0.14B | $0.05B | 2.87 |
| 2019-09-30 | $0.14B | $0.04B | 3.11 |
| 2019-06-30 | $0.15B | $0.04B | 3.72 |
| 2019-03-31 | $0.16B | $0.04B | 4.37 |
| 2018-12-31 | $0.18B | $0.04B | 4.34 |
| 2018-09-30 | $0.09B | $0.03B | 2.62 |
| 2018-06-30 | $0.09B | $0.03B | 3.16 |
| 2018-03-31 | $0.09B | $0.03B | 3.16 |
| 2017-12-31 | $0.08B | $0.03B | 2.58 |
| 2017-09-30 | $0.08B | $0.04B | 2.28 |
| 2017-06-30 | $0.08B | $0.03B | 2.56 |
| 2017-03-31 | $0.08B | $0.03B | 2.79 |
| 2016-12-31 | $0.09B | $0.03B | 2.97 |
| 2016-09-30 | $0.08B | $0.03B | 3.19 |
| 2016-06-30 | $0.09B | $0.03B | 3.43 |
| 2016-03-31 | $0.07B | $0.03B | 2.50 |
| 2015-12-31 | $0.08B | $0.03B | 2.37 |
| 2015-09-30 | $0.08B | $0.04B | 2.15 |
| 2015-06-30 | $0.09B | $0.03B | 3.01 |
| 2015-03-31 | $0.09B | $0.03B | 3.79 |
| 2014-12-31 | $0.09B | $0.03B | 3.65 |
| 2014-09-30 | $0.09B | $0.02B | 4.14 |
| 2014-06-30 | $0.09B | $0.02B | 5.50 |
| 2014-03-31 | $0.11B | $0.02B | 6.70 |
| 2013-12-31 | $0.05B | $0.03B | 1.97 |
| 2013-09-30 | $0.05B | $0.02B | 2.98 |
| 2013-06-30 | $0.05B | $0.01B | 3.99 |
| 2013-03-31 | $0.05B | $0.01B | 4.28 |
| 2012-12-31 | $0.03B | $0.01B | 2.34 |
| 2012-09-30 | $0.03B | $0.01B | 2.60 |
| 2012-06-30 | $0.03B | $0.01B | 2.68 |
| 2012-03-31 | $0.03B | $0.01B | 2.80 |
| 2011-12-31 | $0.03B | $0.01B | 2.89 |
| 2011-09-30 | $0.03B | $0.01B | 3.18 |
| 2011-06-30 | $0.03B | $0.01B | 3.12 |
| 2011-03-31 | $0.03B | $0.01B | 2.95 |
| 2010-12-31 | $0.03B | $0.01B | 2.35 |
| 2010-09-30 | $0.03B | $0.02B | 2.06 |
| 2010-06-30 | $0.03B | $0.01B | 2.22 |
| 2010-03-31 | $0.03B | $0.01B | 2.53 |
| 2009-12-31 | $0.03B | $0.01B | 2.66 |
| 2009-09-30 | $0.03B | $0.01B | 2.74 |
| 2009-06-30 | $0.03B | $0.01B | 3.39 |
| 2009-03-31 | $0.02B | $0.01B | 4.15 |
| 2008-12-31 | $0.03B | $0.01B | 3.22 |
| 2008-09-30 | $0.03B | $0.01B | 3.35 |
| 2008-06-30 | $0.03B | $0.01B | 3.91 |
| 2008-03-31 | $0.03B | $0.01B | 3.23 |
| 2007-12-31 | $0.03B | $0.01B | 3.67 |
| 2007-09-30 | $0.03B | $0.01B | 4.55 |
| 2007-06-30 | $0.04B | $0.01B | 4.44 |
| 2007-03-31 | $0.03B | $0.01B | 3.38 |
| 2006-12-31 | $0.03B | $0.01B | 4.01 |
| 2006-09-30 | $0.03B | $0.01B | 4.90 |
| 2006-06-30 | $0.03B | $0.01B | 5.83 |
| 2006-03-31 | $0.04B | $0.01B | 6.50 |
| 2005-12-31 | $0.04B | $0.01B | 7.25 |
| 2005-09-30 | $0.05B | $0.01B | 7.58 |
| 2005-06-30 | $0.01B | $0.01B | 1.43 |
| 2005-03-31 | $0.00B | 0.00 | |
| 2004-09-30 | $0.00B | 0.00 | |
| 2004-06-30 | $0.00B | 0.00 | |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Products Manufacturing | $1.593B | $0.465B |
| AtriCure, Inc. is a medical device company focused on developing, manufacturing and selling innovative surgical devices to create precise lesions, or scars, in soft tissues. Medical journals have described the adoption by leading cardiothoracic surgeons of the AtriCure, Inc. bipolar ablation system as a standard treatment alternative during open-heart surgical procedures to safely, rapidly and reliably create lesions in cardiac, or heart, tissue to block the abnormal electrical impulses that cause atrial fibrillation, a quivering of the upper chambers of the heart. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Abbott Laboratories (ABT) | United States | $219.724B | 25.32 |
| EssilorLuxottica (ESLOY) | France | $166.677B | 0.00 |
| Boston Scientific (BSX) | United States | $148.274B | 33.90 |
| Stryker (SYK) | United States | $136.154B | 27.03 |
| Medtronic (MDT) | Ireland | $118.264B | 16.67 |
| Lonza Group Ag (LZAGY) | Switzerland | $46.513B | 0.00 |
| Agilent Technologies (A) | United States | $41.601B | 26.92 |
| ResMed (RMD) | United States | $36.703B | 25.40 |
| GE HealthCare Technologies (GEHC) | United States | $33.276B | 15.91 |
| Koninklijke Philips (PHG) | Netherlands | $27.125B | 17.72 |
| Terumo (TRUMY) | Japan | $23.970B | 28.40 |
| Insulet (PODD) | United States | $22.513B | 69.83 |
| Zimmer Biomet Holdings (ZBH) | United States | $17.539B | 10.94 |
| Smith & Nephew SNATS (SNN) | United Kingdom | $14.183B | 0.00 |
| Sunny Optical Technology (SNPTF) | China | $11.495B | 0.00 |
| Baxter (BAX) | United States | $9.253B | 7.47 |
| Bio-Rad Laboratories (BIO) | United States | $8.242B | 29.64 |
| Demant (WILYY) | Denmark | $7.359B | 0.00 |
| ICU Medical (ICUI) | United States | $3.460B | 21.97 |
| Lantheus Holdings (LNTH) | United States | $3.387B | 10.32 |
| Haemonetics (HAE) | United States | $3.200B | 14.24 |
| Envista Holdings (NVST) | United States | $3.198B | 18.35 |
| Shandong Weigao Medical Polymer (SHWGF) | China | $3.120B | 0.00 |
| Prestige Consumer Healthcare (PBH) | United States | $2.883B | 13.15 |
| Perrigo (PRGO) | Ireland | $1.987B | 4.98 |
| LeMaitre Vascular (LMAT) | United States | $1.965B | 39.64 |
| Curaleaf Holdings (CURLF) | Canada | $1.793B | 0.00 |
| Phibro Animal Health (PAHC) | United States | $1.774B | 17.72 |
| Green Thumb Industries (GTBIF) | United States | $1.449B | 63.49 |
| Tilray Brands (TLRY) | Canada | $1.392B | 0.00 |
| Neogen (NEOG) | United States | $1.391B | 26.67 |
| QuidelOrtho (QDEL) | United States | $1.382B | 8.89 |
| Kestra Medical Technologies (KMTS) | United States | $1.349B | 0.00 |
| AdaptHealth (AHCO) | United States | $1.285B | 18.63 |
| BioLife Solutions (BLFS) | United States | $1.242B | 370.43 |
| InMode (INMD) | Israel | $0.913B | 10.32 |
| Valneva SE (VALN) | France | $0.750B | 0.00 |
| Maravai LifeSciences Holdings (MRVI) | United States | $0.733B | 0.00 |
| VAREX IMAGING (VREX) | United States | $0.497B | 17.10 |
| Verano Holdings (VRNO) | United States | $0.478B | 0.00 |
| SNDL (SNDL) | Canada | $0.468B | 0.00 |
| Omeros (OMER) | United States | $0.448B | 0.00 |
| CeriBell (CBLL) | United States | $0.444B | 0.00 |
| Evolus (EOLS) | United States | $0.425B | 0.00 |
| Surmodics (SRDX) | United States | $0.383B | 0.00 |
| Cresco Labs (CRLBF) | United States | $0.381B | 0.00 |
| Cerus (CERS) | United States | $0.328B | 0.00 |
| Brainsway (BWAY) | Israel | $0.296B | 59.96 |
| SEMPERIT AG HLD (SEIGY) | Austria | $0.286B | 0.00 |
| Canopy Growth (CGC) | Canada | $0.281B | 0.00 |
| Capricor Therapeutics (CAPR) | United States | $0.271B | 0.00 |
| Sanuwave Health (SNWV) | United States | $0.267B | 0.00 |
| High Tide (HITI) | Canada | $0.258B | 0.00 |
| Aurora Cannabis (ACB) | Canada | $0.256B | 151.67 |
| Sanara MedTech (SMTI) | United States | $0.247B | 0.00 |
| Owens & Minor (OMI) | United States | $0.246B | 2.47 |
| Viemed Healthcare (VMD) | United States | $0.242B | 19.30 |
| Quanterix (QTRX) | United States | $0.230B | 0.00 |
| TriSalus Life Sciences (TLSI) | United States | $0.219B | 0.00 |
| Exagen (XGN) | United States | $0.217B | 0.00 |
| Organigram Global (OGI) | Canada | $0.206B | 0.00 |
| TerrAscend (TSNDF) | Canada | $0.205B | 0.00 |
| Vireo Growth (VREOF) | United States | $0.195B | 0.00 |
| Utah Medical Products (UTMD) | United States | $0.184B | 16.22 |
| FitLife Brands (FTLF) | United States | $0.172B | 0.00 |
| OraSure Technologies (OSUR) | United States | $0.172B | 0.00 |
| Apyx Medical (APYX) | United States | $0.148B | 0.00 |
| Biote (BTMD) | United States | $0.134B | 5.42 |
| Jushi Holdings (JUSHF) | United States | $0.118B | 0.00 |
| Sharps Technology (STSS) | United States | $0.109B | 0.00 |
| Quipt Home Medical (QIPT) | United States | $0.107B | 0.00 |
| Fonar (FONR) | United States | $0.091B | 11.95 |
| Oramed Pharmaceuticals (ORMP) | United States | $0.090B | 0.00 |
| MacroGenics (MGNX) | United States | $0.087B | 0.00 |
| Agape ATP (ATPC) | $0.062B | 0.00 | |
| ImmuCell (ICCC) | United States | $0.055B | 32.10 |
| Nephros (NEPH) | United States | $0.049B | 35.38 |
| Cytosorbents (CTSO) | United States | $0.044B | 0.00 |
| Jin Medical (ZJYL) | China | $0.042B | 0.00 |
| Veru (VERU) | United States | $0.038B | 0.00 |
| Rockwell Medical (RMTI) | United States | $0.034B | 0.00 |
| Bonk (BNKK) | United States | $0.033B | 0.00 |
| Zynex (ZYXI) | United States | $0.032B | 0.00 |
| United-Guardian (UG) | United States | $0.029B | 14.77 |
| Modular Medical (MODD) | United States | $0.029B | 0.00 |
| Allurion Technologies (ALUR) | United States | $0.012B | 0.00 |
| Cellectar Biosciences (CLRB) | United States | $0.011B | 0.00 |
| INLIF (INLF) | China | $0.011B | 0.00 |
| Meihua Medical Technologies (MHUA) | China | $0.007B | 0.00 |
| IM Cannabis (IMCC) | Canada | $0.007B | 0.00 |
| Flora Growth (FLGC) | United States | $0.006B | 0.00 |
| GlucoTrack (GCTK) | United States | $0.005B | 0.00 |
| Innovative Eyewear (LUCY) | United States | $0.005B | 0.00 |
| Akanda (AKAN) | Canada | $0.001B | 0.00 |
| Trinity Biotech (TRIB) | Ireland | $0.000B | 0.00 |
| InVivo Therapeutics Holdings (NVIVQ) | United States | $0.000B | 0.00 |
| InterCure (INCR) | Israel | $0.000B | 0.00 |